Strategic Multilayer Assessment Special Topics Paper : The COVID Crisis: Implications for United States- and Global- Biosecurity

Abstract

The United States (US) engagement of public health resources to meet the current SARS-CoV-2 (COVID-19) crisis has revealed vulnerabilities in testing and treatment components of biosecurity. Facing a severe shortage of available testing kits, the US Centers for Disease Control (CDC) attempted to develop its own test for COVID-19, rather than following World Health Organization (WHO) recommendations for testing methods1. The lack of tests has made it difficult to track exactly how many people within each state, as well as the US at-large have been affected, which has implications both for the extent of public health response, and considerations for approaches to stabilize and sustain the national economy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 22, 2020
Accession Number
AD1097149

Entities

People

  • James Giordano
  • Vikram Venkatram

Organizations

  • Georgetown University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Antiviral Agents
  • Blood
  • Chemical Reactions
  • Covid-19
  • Disease Outbreaks
  • Health Services
  • Medical Personnel
  • Microbiology
  • National Security
  • Polymerase Chain Reaction
  • Public Health
  • Sars
  • Security
  • Synthetic Biology
  • Therapy
  • United States
  • Viruses

Readers

  • Infectious Disease/Epidemiology
  • Political Violence and Terrorism Studies.
  • Software Engineering